Literature DB >> 15870300

TAF1 histone acetyltransferase activity in Sp1 activation of the cyclin D1 promoter.

Traci L Hilton1, Yun Li, Elizabeth L Dunphy, Edith H Wang.   

Abstract

A missense mutation within the histone acetyltransferase (HAT) domain of the TATA binding protein-associated factor TAF1 induces ts13 cells to undergo a late G(1) arrest and decreases cyclin D1 transcription. We have found that TAF1 mutants (Delta844-850 and Delta848-850, from which amino acids 844 through 850 and 848 through 850 have been deleted, respectively) deficient in HAT activity are unable to complement the ts13 defect in cell proliferation and cyclin D1 transcription. Chromatin immunoprecipitation assays revealed that histone H3 acetylation was reduced at the cyclin D1 promoter but not the c-fos promoter upon inactivation of TAF1 in ts13 cells. The hypoacetylation of H3 at the cyclin D1 promoter was reversed by treatment with trichostatin A (TSA), a histone deacetylase inhibitor, or by expression of TAF1 proteins that retain HAT activity. Transcription of a chimeric promoter containing the Sp1 sites of cyclin D1 and c-fos core remained TAF1 dependent in ts13 cells. Treatment with TSA restored full activity to the cyclin D1-c-fos chimera at 39.5 degrees C. In vivo genomic footprinting experiments indicate that protein-DNA interactions at the Sp1 sites of the cyclin D1 promoter were compromised at 39.5 degrees C in ts13 cells. These data have led us to hypothesize that TAF1-dependent histone acetylation facilitates transcription factor binding to the Sp1 sites, thereby activating cyclin D1 transcription and ultimately G(1)-to-S-phase progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15870300      PMCID: PMC1087727          DOI: 10.1128/MCB.25.10.4321-4332.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

1.  Differential regulation of transcription of p21 and cyclin D1 conferred by TAF(II)250.

Authors:  J J Rushton; R A Steinman; P D Robbins
Journal:  Cell Growth Differ       Date:  1997-10

2.  Sp1, but not Sp3, functions to mediate promoter activation by TGF-beta through canonical Sp1 binding sites.

Authors:  J M Li; M B Datto; X Shen; P P Hu; Y Yu; X F Wang
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

Review 3.  Roles of histone acetyltransferases and deacetylases in gene regulation.

Authors:  M H Kuo; C D Allis
Journal:  Bioessays       Date:  1998-08       Impact factor: 4.345

4.  CCG1/TAF(II)250 regulates epidermal growth factor receptor gene transcription in cell cycle mutant ts13.

Authors:  G A Vargas; J M Isas; E Fantino; J J Gargus; H T Haigler
Journal:  J Cell Physiol       Date:  1998-09       Impact factor: 6.384

Review 5.  Histone acetylation and transcriptional regulatory mechanisms.

Authors:  K Struhl
Journal:  Genes Dev       Date:  1998-03-01       Impact factor: 11.361

6.  TAFII250-dependent transcription of cyclin A is directed by ATF activator proteins.

Authors:  E H Wang; S Zou; R Tjian
Journal:  Genes Dev       Date:  1997-10-15       Impact factor: 11.361

7.  Small-scale density gradient sedimentation to separate and analyze multiprotein complexes.

Authors:  N Tanese
Journal:  Methods       Date:  1997-07       Impact factor: 3.608

8.  Nerve growth factor induces transcription of the p21 WAF1/CIP1 and cyclin D1 genes in PC12 cells by activating the Sp1 transcription factor.

Authors:  G Z Yan; E B Ziff
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

9.  Histone acetyltransferase activity of yeast Gcn5p is required for the activation of target genes in vivo.

Authors:  M H Kuo; J Zhou; P Jambeck; M E Churchill; C D Allis
Journal:  Genes Dev       Date:  1998-03-01       Impact factor: 11.361

10.  Yeast TAF(II)145 required for transcription of G1/S cyclin genes and regulated by the cellular growth state.

Authors:  S S Walker; W C Shen; J C Reese; L M Apone; M R Green
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

View more
  28 in total

1.  Genome-wide relationships between TAF1 and histone acetyltransferases in Saccharomyces cerevisiae.

Authors:  Melissa Durant; B Franklin Pugh
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

2.  Structures of three distinct activator-TFIID complexes.

Authors:  Wei-Li Liu; Robert A Coleman; Elizabeth Ma; Patricia Grob; Joyce L Yang; Yixi Zhang; Gina Dailey; Eva Nogales; Robert Tjian
Journal:  Genes Dev       Date:  2009-07-01       Impact factor: 11.361

3.  Yeast Rap1 contributes to genomic integrity by activating DNA damage repair genes.

Authors:  Raghuvir S Tomar; Suting Zheng; Deborah Brunke-Reese; Holly N Wolcott; Joseph C Reese
Journal:  EMBO J       Date:  2008-05-15       Impact factor: 11.598

Review 4.  TAF7: traffic controller in transcription initiation.

Authors:  Anne Gegonne; Ballachanda N Devaiah; Dinah S Singer
Journal:  Transcription       Date:  2013 Jan-Feb

5.  Genetic landscape of clear cell endometrial cancer and the era of precision medicine.

Authors:  Gloria S Huang; Alessandro D Santin
Journal:  Cancer       Date:  2017-05-09       Impact factor: 6.860

6.  Frameshift Mutations in the Mononucleotide Repeats of TAF1 and TAF1L Genes in Gastric and Colorectal Cancers with Regional Heterogeneity.

Authors:  Hye Rim Oh; Chang Hyeok An; Nam Jin Yoo; Sug Hyung Lee
Journal:  Pathol Oncol Res       Date:  2016-08-29       Impact factor: 3.201

7.  Effects of trichostatin A on neuronal mu-opioid receptor gene expression.

Authors:  Ying-Chih Lin; Kelly E Flock; Ryan J Cook; Amanda J Hunkele; Horace H Loh; Jane L Ko
Journal:  Brain Res       Date:  2008-10-11       Impact factor: 3.252

8.  Transforming growth factor-beta regulates basal transcriptional regulatory machinery to control cell proliferation and differentiation in cranial neural crest-derived osteoprogenitor cells.

Authors:  Jun-ichi Iwata; Ryoichi Hosokawa; Pedro A Sanchez-Lara; Mark Urata; Harold Slavkin; Yang Chai
Journal:  J Biol Chem       Date:  2009-12-03       Impact factor: 5.157

9.  Diazoxide-mediated growth inhibition in human lung cancer cells via downregulation of beta-catenin-mediated cyclin D1 transcription.

Authors:  Jianyong Ding; Di Ge; Weigang Guo; Chunlai Lu
Journal:  Lung       Date:  2008-12-04       Impact factor: 2.584

10.  Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.

Authors:  Siming Zhao; Murim Choi; John D Overton; Stefania Bellone; Dana M Roque; Emiliano Cocco; Federica Guzzo; Diana P English; Joyce Varughese; Sara Gasparrini; Ileana Bortolomai; Natalia Buza; Pei Hui; Maysa Abu-Khalaf; Antonella Ravaggi; Eliana Bignotti; Elisabetta Bandiera; Chiara Romani; Paola Todeschini; Renata Tassi; Laura Zanotti; Luisa Carrara; Sergio Pecorelli; Dan-Arin Silasi; Elena Ratner; Masoud Azodi; Peter E Schwartz; Thomas J Rutherford; Amy L Stiegler; Shrikant Mane; Titus J Boggon; Joseph Schlessinger; Richard P Lifton; Alessandro D Santin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.